Alloplex Biotherapeutics Stock

alloplexbio.comHealthcareFounded: 2016Funding to Date: $20.67MM

Alloplex Biotherapeutics is a biotechnology company that is developing novel, off-the-shelf allogeneic cell therapies for the treatment of cancer and other diseases. The company's proprietary platform, AlloCARâ„¢, enables the engineering of T cells to express chimeric antigen receptors (CARs) that can recognize and attack tumor cells. Alloplex Biotherapeutics aims to transform the field of cell therapy by providing a scalable, cost-effective, and personalized approach to cancer treatment.

Register for Details

For more details on financing and valuation for Alloplex Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Alloplex Biotherapeutics.

Register Today

Other companies like Alloplex Biotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B